Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433378 · ClinicalTrials.gov registry record · Early Phase 1
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
A Early Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 700
- Enrollment target
NCT03433378: Completed Early Phase 1 study, sponsored by Sun Pharmaceutical Industries.
NCT03433378 is a Early Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 700 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (1221% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03433378, a Early Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 700 participants
- Enrollment target
Study Summary
Bioequivalence study comparing Tretinoin Cream, 0.05% to RETIN-A®.
Primary Outcome
Demonstration of Bioequivalence in Percent change in inflammatory and non-inflammatory lesion counts
Interventions
- DRUG Vehicle of the test product
- DRUG Tretinoin cream, 0.05%
- DRUG RETIN-A® (tretinoin) cream, 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2018-01-26 |
| Phase | Early Phase 1 |
What the finished NCT03433378 record still lists
NCT03433378 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (1221% higher).
The record links to 0 conditions, and to 3 interventions - of which Vehicle of the test product is the first listed.
NCT03433378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03433378 about?
NCT03433378 is a clinical study titled "To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris". Bioequivalence study comparing Tretinoin Cream, 0.05% to RETIN-A®.
What is the current status of trial NCT03433378?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 700 participants. The study started on 2017-08-04. Estimated completion is 2018-01-26.
What interventions are being tested in trial NCT03433378?
The interventions under investigation include: Vehicle of the test product (DRUG), Tretinoin cream, 0.05% (DRUG), RETIN-A® (tretinoin) cream, 0.05% (DRUG).
Who is sponsoring clinical trial NCT03433378?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03433378's enrollment target sits among peer trials
700 15th of 2000 higher than 1,986 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI